Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)
Others
Ratios

Addex Therapeutics (ADXN) Non Operating Income: 2022-2024

Historic Non Operating Income for Addex Therapeutics (ADXN) over the last 3 years, with Dec 2024 value amounting to $26,199.

  • Addex Therapeutics' Non Operating Income rose 160.83% to $76.9 billion in Q4 2024 from the same period last year, while for Dec 2024 it was $4.0 billion, marking a year-over-year increase of 264.10%. This contributed to the annual value of $26,199 for FY2024, which is 109.15% up from last year.
  • Per Addex Therapeutics' latest filing, its Non Operating Income stood at $26,199 for FY2024, which was up 109.15% from -$286,362 recorded in FY2023.
  • Over the past 5 years, Addex Therapeutics' Non Operating Income peaked at $26,199 during FY2024, and registered a low of -$286,362 during FY2023.
  • Over the past 3 years, Addex Therapeutics' median Non Operating Income value was -$275,756 (recorded in 2022), while the average stood at -$178,640.
  • Per our database at Business Quant, Addex Therapeutics' Non Operating Income fell by 3.85% in 2023 and then skyrocketed by 109.15% in 2024.
  • Yearly analysis of 3 years shows Addex Therapeutics' Non Operating Income stood at -$275,756 in 2022, then dropped by 3.85% to -$286,362 in 2023, then surged by 109.15% to $26,199 in 2024.